News Archive for 2010
New Funding Opportunities section details over 100 upcoming grants worth millions
Our new Funding Opportunities section offers details for well over one hundred grant schemes from both the UK and overseas, calling for proposals and offering awards from just a few hundred pounds to hundreds of thousands of pounds and more.
The Times commends Professor Chris Hawkey as one of Britain’s top doctors
The Times recently published a directory of Britain’s top doctors that featured NUH’s Professor of Gastroenterology Chris Hawkey. Introducing the section, Times Medical Correspondent Dr Mark Porter said: “Over the past six months a team of Times researchers asked charities, specialists and professional bodies and associations to come up with a list of leaders in [...]
Nottingham Digestive Diseases Centre BRU brochure published
The latest NIHR Nottingham Digestive Diseases Centre Biomedical Research Unit brochure has just been released. The publication details the aims of the NIHR BRU and gives an overview of its facilities.
Nottingham joins world first Respiratory Cluster
A world-first initiative to boost partnership between academics, clinicians and the life sciences industry includes Nottingham amongst the country’s first centres of excellence. Setting Nottingham respiratory research within a premier grouping of leading biomedical centres, the partnership will provide the right commercial and cultural environment to maintain and grow world-class research and development.
Acclaimed film director Ken Loach opens innovative Nottingham Hearing BRU Family Lab
Cannes Palm D’Or winner Ken Loach opened the NIHR Hearing BRU‘s new Family Lab in early November at Ropewalk House, Nottingham. The lab explores pioneering ways of improving communication between parents and children with hearing difficulties.
Nottingham Prognostic Index Plus (NPI+): A Ground Breaking Tool for Breast Cancer
The Nottingham Prognostic Index Plus (NPI+) is an award winning decision making tool for clinicians to offer personalised medicine to all female patients with breast cancer. NPI+ builds considerably upon the original NPI that was developed in Nottingham in the early 1980s. NPI+ includes ground breaking functionality by predicting both clinical outcomes (survival) and by aiding customised therapeutics. NPI+ can be used for all female breast cancer patients, not just those who are oestrogen receptor positive.
A new guide to NUH R&D finance processes
A comprehensive guide to NUH R&D finance has been written, collated and published by our Corporate Finance Manager Paul Barnett. Available on this site, it includes valuable information for anyone needing to cost a project and go though the financial logistics that are a crucial part of any successful study.
Being a good research partner: the virtues and rewards
Research is crucial to the NHS. It helps the NHS understand, adapt and respond to the challenges it faces. These challenges might come from changes in policy, populations, technologies or disease patterns. In the present climate, research evidence can play a key role in helping the NHS respond to the challenge of improving quality while [...]
Nottingham Research Biobank gains Ethics Approval
The Nottingham Research Biobank has now received Ethical Approval. This is the first formal step in our co-ordinated biobanking and patient informatics strategy. The Ethics approval itself has a number of unique features, and is by far the most comprehensive in the UK. It includes: generic consent for biobanking embedded in all Trust surgical/diagnostic consent [...]
East Midlands Regional Innovation Fund
The East Midlands Regional Innovation Fund for 2010/11 is now open for applications and will close on Friday 10th September 2010. The primary aim of the 2010/11 RIF is to support the delivery of the Quality, Innovation, Productivity and Prevention (QIPP) challenge in 2010/11. Successful applications will be able to demonstrate a direct impact on [...]
